{"collection_id":"hcc_tace_seg","collection_name":"HCC-TACE-Seg","cancer_types":"Hepatocellular carcinoma","tumor_locations":"Liver","species":"Human","subjects":105,"supporting_data":"Clinical, Image Analyses, Software/Source Code","description":"Despite surveillance, the majority of HCC cases are diagnosed at advanced stages that can be treated\nonly using (Transarterial chemoembolization) TACE, or systemic therapy. TACE failure can occur to\n60% of patients receiving the procedure, with subsequent financial and emotional burden. Radiomics\nhave emerged as a new tool capable of predicting tumor response to TACE from pre-procedural CT\nstudy.\nThis retrospectively acquired data collection includes pre- and post-procedure CT imaging studies of\n105 confirmed HCC patients who underwent TACE between 2002 and 2012 with an available treatment\noutcome, in the form of time-to-progression and overall survival.\nPlease see the HCC-TACE-Seg (https://doi.org/10.7937/TCIA.5FNA-0924) wiki page to learn more about\nthe images and to obtain any supporting metadata for this collection.","patients":105,"studies":211,"series":1020,"instances":52311,"size_TB":0.03,"modalities":["CT","SEG"],"licenses":[{"license_short_name":"CC BY 4.0","series":1020,"size_TB":0.03}]}